BBC Stock Overview
ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF is an exchange traded fund launched and managed by Virtus ETF Advisers LLC.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$27.56 |
52 Week High | US$31.99 |
52 Week Low | US$16.88 |
Beta | 0 |
1 Month Change | -12.09% |
3 Month Change | 14.32% |
1 Year Change | 27.89% |
3 Year Change | -45.98% |
5 Year Change | -5.01% |
Change since IPO | -0.35% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
BBC | US Capital Markets | US Market | |
---|---|---|---|
7D | -2.8% | -0.1% | -0.2% |
1Y | 27.9% | 32.3% | 25.7% |
Return vs Industry: BBC underperformed the US Capital Markets industry which returned 31.7% over the past year.
Return vs Market: BBC exceeded the US Market which returned 25.8% over the past year.
Price Volatility
BBC volatility | |
---|---|
BBC Average Weekly Movement | 5.1% |
Capital Markets Industry Average Movement | 3.3% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: BBC has not had significant price volatility in the past 3 months.
Volatility Over Time: BBC's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2014 | n/a | n/a | https://www.virtus.com/products/lifesci-biotechnology-clinical-trials-etf#shareclass.619/period.quarterly |
ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF is an exchange traded fund launched and managed by Virtus ETF Advisers LLC. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors.
ETFis Series Trust I - Virtus LifeSci Biotech Clinical Trials ETF Fundamentals Summary
BBC fundamental statistics | |
---|---|
Market cap | US$11.44m |
Earnings (TTM) | US$0 |
Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs BBC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BBC income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | US$0 |
Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did BBC perform over the long term?
See historical performance and comparison